Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer

Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer

(2015) Katarina Davalieva et al.   Proteome Science

Comparative Proteomic Analysis of Anti-Cancer Mechanism by Periplocin Treatment in Lung Cancer Cells

(2014) Zejun Lu et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9

(2014) Marcos A. Muñiz Lino et al.   Journal of Proteomics

A small-molecule inhibitor of UBE2N induces neuroblastoma cell death via activation of p53 and JNK pathways

(2014) J Cheng et al.   Cell Death & Disease

The Wnt signalling pathway is upregulated in an in vitro model of acquired tamoxifen resistant breast cancer

(2013) Yan Ni Loh et al.   BMC CANCER

Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer

(2013) Arantza Fariña Sarasqueta et al.   BMC CANCER

Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer

(2013) Byungho Lim et al.   CARCINOGENESIS

Ubiquitin — omics reveals novel networks and associations with human disease

(2013) Benedikt M Kessler   CURRENT OPINION IN CHEMICAL BIOLOGY

Current Status of Biomarkers for Prostate Cancer

(2013) Vicki Velonas et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Decreased expression of SERPINB1 correlates with tumor invasion and poor prognosis in hepatocellular carcinoma

(2013) Xiaopeng Cui et al.   JOURNAL OF MOLECULAR HISTOLOGY

Identification of proteomic signatures associated with lung cancer and COPD

(2013) M.D. Pastor et al.   Journal of Proteomics

Integrated genomic characterization of endometrial carcinoma

(2013) Gad Getz et al.   NATURE

Proteomic Analysis Reveals that Proteasome Subunit Beta 6 Is Involved in Hypoxia-Induced Pulmonary Vascular Remodeling in Rats

(2013) Jian Wang et al.   PLoS One

Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia

(2013) T. Velusamy et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma

(2013) Yi-Jun Qi et al.   PROTEOMICS

Inhibition of proliferation and survival of diffuse large B-cell lymphoma cells by a small-molecule inhibitor of the ubiquitin-conjugating enzyme Ubc13-Uev1A

(2012) M. Pulvino et al.   BLOOD

The role of proteomics in prostate cancer research: Biomarker discovery and validation

(2012) Elisa Pin et al.   CLINICAL BIOCHEMISTRY

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

Comparative Proteomic Analysis of Colon Cancer Cell HCT-15 in Response to All-Trans Retinoic Acid Treatment

(2012) Jie Zhao et al.   PROTEIN AND PEPTIDE LETTERS

Beyond PSA: The Next Generation of Prostate Cancer Biomarkers

(2012) J. R. Prensner et al.   Science Translational Medicine

Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma

(2011) Alaiya   INTERNATIONAL JOURNAL OF ONCOLOGY

Differential expression patterns of capping protein, protein phosphatase 1, and casein kinase 1 may serve as diagnostic markers for malignant melanoma

(2011) Daxin Sun et al.   MELANOMA RESEARCH

Profilin 1 is a Potential Biomarker for Bladder Cancer Aggressiveness

(2011) Jerome Zoidakis et al.   MOLECULAR & CELLULAR PROTEOMICS

Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform

(2011) Ramesh Ummanni et al.   PLoS One

Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics

(2011) Guang-Rong Yan et al.   PROTEOMICS

How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

(2010) Yohannes Mebratu et al.   CELL CYCLE

A Combined Proteomics and Metabolomics Profiling of Gastric Cardia Cancer Reveals Characteristic Dysregulations in Glucose Metabolism

(2010) Zhen Cai et al.   MOLECULAR & CELLULAR PROTEOMICS

Small-molecule inhibition of APT1 affects Ras localization and signaling

(2010) Frank J Dekker et al.   Nature Chemical Biology

Evaluation of Zinc-α-2-Glycoprotein and Proteasome Subunit β-Type 6 Expression in Prostate Cancer Using Tissue Microarray Technology

(2010) Gillian OʼHurley et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

Searching for serum tumor markers for colorectal cancer using a 2-D DIGE approach

(2009) Yanlei Ma et al.   ELECTROPHORESIS

Transaldolase: From biochemistry to human disease

(2009) Anne K. Samland et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Androgen Receptor Phosphorylation and Activity Are Regulated by an Association with Protein Phosphatase 1

(2009) Shaoyong Chen et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Germline genomic variants associated with childhood acute lymphoblastic leukemia

(2009) Lisa R Treviño et al.   NATURE GENETICS

Serine protease inhibitor (SERPIN) B1 promotes oral cancer cell motility and is over-expressed in invasive oral squamous cell carcinoma

(2009) Mei-Yu Tseng et al.   ORAL ONCOLOGY

Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma

(2009) Keun Na et al.   PROTEOMICS

Biomarkers for Prostate Cancer

(2008) Danil V. Makarov et al.   Annual Review of Medicine

Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer

(2008) Ramesh Ummanni et al.   CANCER LETTERS

2D-DIGE as a Strategy To Identify Serum Markers for the Progression of Prostate Cancer

(2008) Jennifer C. Byrne et al.   JOURNAL OF PROTEOME RESEARCH

Mining the plasma proteome for cancer biomarkers

(2008) Samir M. Hanash et al.   NATURE